Published time: 06 May 2020
Authors: Miriam Merad & Jerome C. Martin,
Keywords: COVID-19, inflammation, SARS-CoV-2, infection, macrophage
Abstract
The COVID-19 pandemic caused by infection with SARS-CoV-2 has led to more than 200,000 deaths worldwide. Several studies have now established that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients. Macrophages are a population of innate immune cells that sense and respond to microbial threats by producing inflammatory molecules that eliminate pathogens and promote tissue repair. However, a dysregulated macrophage response can be damaging to the host, as is seen in the macrophage activation syndrome induced by severe infections, including in infections with the related virus SARS-CoV. Here we describe the potentially pathological roles of macrophages during SARS-CoV-2 infection and discuss ongoing and prospective therapeutic strategies to modulate macrophage activation in patients with COVID-19.
Pathological inflammation in patients with COVID-19 a key role for monocytes and macrophages
Reference: https://www.nature.com/articles/s41577-020-0331-4
Leave a Comment